MARKET

RHHBY

RHHBY

Roche Hldg
OTCQX
50.54
-1.33
-2.56%
Closed 15:59 07/13 EDT
OPEN
51.47
PREV CLOSE
51.87
HIGH
51.62
LOW
50.49
VOLUME
200.58K
TURNOVER
10.18M
52 WEEK HIGH
59.03
52 WEEK LOW
36.39
MARKET CAP
278.55B
P/E (TTM)
20.00
1D
5D
1M
3M
1Y
5Y
1D
Cue Biopharma names Dominic Borie chief medical officer, head of R&D
PUBT · 12h ago
Weekly Report: what happened at RHHBY last week (0706-0710)?
Weekly Report · 15h ago
Mark Cuban Pushes Back on AI Doctors, Says Healthcare Conglomerates Will 'Delay and Deny' Progress
Benzinga · 17h ago
Ionis extends losses as Roche scraps two partnered studies
Seeking Alpha · 3d ago
Nurix Therapeutics price target raised to $34 from $32 at Truist
TipRanks · 3d ago
Nurix Therapeutics price target raised to $33 from $30 at RBC Capital
TipRanks · 3d ago
Nurix Therapeutics Q2 revenue falls sharply, net loss widens; strikes up to $2.3 bln collab with Roche
Reuters · 4d ago
Teva, Polpharma ink licensing pact for biosimilar targeting Roche’s Ocrevus
Seeking Alpha · 4d ago
More
About RHHBY
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Webull offers Roche Holding AG (ADR) stock information, including OTCQX: RHHBY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RHHBY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RHHBY stock methods without spending real money on the virtual paper trading platform.